159 related articles for article (PubMed ID: 38523399)
21. Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UK.
Daskalopoulou M; Lampe FC; Sherr L; Phillips AN; Johnson MA; Gilson R; Perry N; Wilkins E; Lascar M; Collins S; Hart G; Speakman A; Rodger AJ;
AIDS Behav; 2017 Jan; 21(1):184-195. PubMed ID: 27586375
[TBL] [Abstract][Full Text] [Related]
22. Uncovering ART adherence inconsistencies: An assessment of sustained adherence among adolescents in South Africa.
Zhou S; Cluver L; Shenderovich Y; Toska E
J Int AIDS Soc; 2021 Oct; 24(10):e25832. PubMed ID: 34708912
[TBL] [Abstract][Full Text] [Related]
23. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
[TBL] [Abstract][Full Text] [Related]
24. Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target.
Djiyou ABD; Penda CI; Madec Y; Ngondi GD; Moukoko A; Varloteaux M; de Monteynard LA; Moins C; Moukoko CEE; Aghokeng AF
BMC Pediatr; 2023 Mar; 23(1):119. PubMed ID: 36922769
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for HIV virological non-suppression among adolescents with common mental disorder symptoms in Zimbabwe: a cross-sectional study.
Simms V; Bernays S; Chibanda D; Chinoda S; Mutsinze A; Beji-Chauke R; Mugurungi O; Apollo T; Sithole D; Verhey R; Weiss HA; Willis N
J Int AIDS Soc; 2021 Aug; 24(8):e25773. PubMed ID: 34402199
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland.
Jobanputra K; Parker LA; Azih C; Okello V; Maphalala G; Kershberger B; Khogali M; Lujan J; Antierens A; Teck R; Ellman T; Kosgei R; Reid T
PLoS One; 2015; 10(2):e0116144. PubMed ID: 25695494
[TBL] [Abstract][Full Text] [Related]
27. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
[TBL] [Abstract][Full Text] [Related]
28. STACKing the odds for adolescent survival: health service factors associated with full retention in care and adherence amongst adolescents living with HIV in South Africa.
Cluver L; Pantelic M; Toska E; Orkin M; Casale M; Bungane N; Sherr L
J Int AIDS Soc; 2018 Sep; 21(9):e25176. PubMed ID: 30240121
[TBL] [Abstract][Full Text] [Related]
29. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
[TBL] [Abstract][Full Text] [Related]
30. Antiretroviral therapy non-adherence among children living with HIV in Dire Dawa, Eastern Ethiopia: a case-control study.
Mengesha MM; Embibel M; Gobena T; Tunje A; Jerene D; Hallström IK
BMC Pediatr; 2022 Nov; 22(1):653. PubMed ID: 36357856
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of adolescents living with HIV receiving care and treatment services in antiretroviral therapy clinics in Cambodia: descriptive findings from a cross-sectional study.
Yi S; Tuot S; Pal K; Khol V; Sok S; Chhoun P; Ferguson L; Mburu G
BMC Health Serv Res; 2018 Oct; 18(1):781. PubMed ID: 30326882
[TBL] [Abstract][Full Text] [Related]
32. High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo.
Salou M; Dagnra AY; Butel C; Vidal N; Serrano L; Takassi E; Konou AA; Houndenou S; Dapam N; Singo-Tokofaï A; Pitche P; Atakouma Y; Prince-David M; Delaporte E; Peeters M
J Int AIDS Soc; 2016; 19(1):20683. PubMed ID: 27125320
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.
Joseph Davey D; Abrahams Z; Feinberg M; Prins M; Serrao C; Medeossi B; Darkoh E
Int J STD AIDS; 2018 May; 29(6):603-610. PubMed ID: 29334886
[TBL] [Abstract][Full Text] [Related]
34. Determinants of viral load non-suppression among adolescents in Mbale District, Eastern Rural Uganda.
Maena J; Banke-Thomas A; Mukiza N; Kuteesa CN; Kakumba RM; Kataike H; Kizito S; Babirye JA; Nakalega R
AIDS Res Ther; 2021 Dec; 18(1):91. PubMed ID: 34863196
[TBL] [Abstract][Full Text] [Related]
35. Determinants of nonsuppression of HIV viral load among children receiving antiretroviral therapy in the Simiyu region: a cross-sectional study.
Mageda K; Kulemba K; Olomi W; Kapologwe N; Katalambula L; Petrucka P
AIDS Res Ther; 2023 Apr; 20(1):22. PubMed ID: 37055786
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China.
Da W; Li X; Qiao S; Zhou Y; Shen Z
PLoS One; 2018; 13(8):e0203032. PubMed ID: 30161177
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study.
Chhim K; Mburu G; Tuot S; Sopha R; Khol V; Chhoun P; Yi S
AIDS Res Ther; 2018 Nov; 15(1):20. PubMed ID: 30445984
[TBL] [Abstract][Full Text] [Related]
38. Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross-sectional and longitudinal analyses.
Jones TPW; Lampe FC; Arenas-Pinto A; Smith C; McDonnell J; Haddow L; Johnson M; Yousef E; Lascar M; Maria Geretti A; Sherr L; Collins S; Phillips AN; Rodger AJ;
HIV Med; 2022 Mar; 23(3):209-226. PubMed ID: 34634176
[TBL] [Abstract][Full Text] [Related]
39. High risk of virologic failure among HIV-infected children and adolescents routinely followed-up in Littoral region of Cameroon.
Mbébi Enoné PJ; Penda CI; Ngondi G; Fokam J; Ebong SB; Mekoulou Ndongo J; Essangui Same EG; Ndjengue Nson LS; Mandengue SH; Eboumbou Moukoko CE
PLoS One; 2023; 18(8):e0289426. PubMed ID: 37561800
[TBL] [Abstract][Full Text] [Related]
40. Achieving equity in HIV-treatment outcomes: can social protection improve adolescent ART-adherence in South Africa?
Cluver LD; Toska E; Orkin FM; Meinck F; Hodes R; Yakubovich AR; Sherr L
AIDS Care; 2016 Mar; 28 Suppl 2(sup2):73-82. PubMed ID: 27392002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
